{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:53:44Z","timestamp":1791122024163,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11568-5","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:02:39Z","timestamp":1777190559000},"page":"8087-8104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rational scaffold discovery for HIV-1 reverse transcriptase inhibitors via integrated in silico approaches"],"prefix":"10.1007","volume":"30","author":[{"given":"Aakanksha","family":"Kunwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzoo","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suruchi","family":"Bhambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash C.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"1","key":"11568_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cpt.1284","volume":"105","author":"C Flexner","year":"2019","unstructured":"Flexner C (2019) Modern Human immunodeficiency virus therapy: progress and prospects. Clin Pharmacol Ther 105(1):61\u201370. https:\/\/doi.org\/10.1002\/cpt.1284","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"11568_CR2","doi-asserted-by":"publisher","first-page":"e70089","DOI":"10.1002\/hsr2.70089","volume":"7","author":"GY Scott","year":"2024","unstructured":"Scott GY, Worku DHIV, Vaccination (2024) Navigating the path to a transformative breakthrough\u2014a review of current evidence. Health Sci Rep 7(9):e70089. https:\/\/doi.org\/10.1002\/hsr2.70089","journal-title":"Health Sci Rep"},{"issue":"1","key":"11568_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s43556-024-00222-x","volume":"5","author":"IN Weerarathna","year":"2024","unstructured":"Weerarathna IN, Doelakeh ES, Kiwanuka L, Kumar P, Arora S (2024) Prophylactic and therapeutic vaccine development: advancements and challenges. Mol Biomed 5(1):57. https:\/\/doi.org\/10.1186\/s43556-024-00222-x","journal-title":"Mol Biomed"},{"issue":"4","key":"11568_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.coi.2006.05.012","volume":"18","author":"C Brander","year":"2006","unstructured":"Brander C, Frahm N, Walker BD (2006) The challenges of host and viral diversity in hiv vaccine design. Curr Opin Immunol 18(4):430\u2013437. https:\/\/doi.org\/10.1016\/j.coi.2006.05.012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"11568_CR5","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","volume":"1","author":"SG Deeks","year":"2015","unstructured":"Deeks SG, Overbaugh J, Phillips A, Buchbinder SHIV, Infection (2015) Nat Rev Dis Primer 1(1):15035. https:\/\/doi.org\/10.1038\/nrdp.2015.35","journal-title":"Nat Rev Dis Primer"},{"key":"11568_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.coph.2020.10.009","volume":"54","author":"M Vanangamudi","year":"2020","unstructured":"Vanangamudi M, Kurup S, Namasivayam V (2020) Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens. Curr Opin Pharmacol 54:179\u2013187. https:\/\/doi.org\/10.1016\/j.coph.2020.10.009","journal-title":"Curr Opin Pharmacol"},{"key":"11568_CR7","doi-asserted-by":"crossref","unstructured":"Sengupta S, Nayak BDNA (2025) Viruses containing reverse transcriptase. Textbook of general virology. Taylor and Francis Group, 15","DOI":"10.1201\/9781003369349-15"},{"issue":"9","key":"11568_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/cmdc.202000849","volume":"16","author":"D Ramesh","year":"2021","unstructured":"Ramesh D, Vijayakumar BG, Kannan T (2021) Advances in nucleoside and nucleotide analogues in tackling human immunodeficiency virus and hepatitis virus infections. Chem Med Chem 16(9):1403\u20131419. https:\/\/doi.org\/10.1002\/cmdc.202000849","journal-title":"ChemMedChem"},{"issue":"5","key":"11568_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/cmdc.202000695","volume":"16","author":"Y Yoshida","year":"2021","unstructured":"Yoshida Y, Honma M, Kimura Y, Abe H (2021) Structure, Synthesis and Inhibition mechanism of nucleoside analogues as HIV-1 reverse transcriptase inhibitors (NRTIs). Chem Med Chem 16(5):743\u2013766. https:\/\/doi.org\/10.1002\/cmdc.202000695","journal-title":"ChemMedChem"},{"issue":"5","key":"11568_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/ph17050661","volume":"17","author":"D Palazzotti","year":"2024","unstructured":"Palazzotti D, Sguilla M, Manfroni G, Cecchetti V, Astolfi A, Barreca ML (2024) Small molecule drugs target viral polymerases pharmaceuticals 17(5):661. https:\/\/doi.org\/10.3390\/ph17050661","journal-title":"Small Molecule Drugs Target Viral Polymerases Pharmaceuticals"},{"issue":"6","key":"11568_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","volume":"10","author":"C Zhuang","year":"2020","unstructured":"Zhuang C, Pannecouque C, De Clercq E, Chen F (2020) Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years. Acta Pharm Sin B 10(6):961\u2013978. https:\/\/doi.org\/10.1016\/j.apsb.2019.11.010","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"11568_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.22080","volume":"45","author":"K Zhang","year":"2025","unstructured":"Zhang K, Zhang Y, Li M, Pannecouque C, De Clercq E, Wang S, Chen F (2025) Deciphering the enigmas of non-nucleoside reverse transcriptase inhibitors (NNRTIs): a medicinal chemistry expedition towards combating HIV Drug Resistance. Med Res Rev 45(2):426\u2013483. https:\/\/doi.org\/10.1002\/med.22080","journal-title":"Med Res Rev"},{"issue":"20","key":"11568_CR13","doi-asserted-by":"publisher","first-page":"22213","DOI":"10.1021\/acsomega.4c01207","volume":"9","author":"AK Oraby","year":"2024","unstructured":"Oraby AK, Bilawchuk L, West FG, Marchant DJ (2024) Structure-based discovery of allosteric inhibitors targeting a new druggable site in the respiratory syncytial virus polymerase. ACS Omega 9(20):22213\u201322229. https:\/\/doi.org\/10.1021\/acsomega.4c01207","journal-title":"ACS Omega"},{"issue":"4","key":"11568_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF03259093","volume":"6","author":"SS Patel","year":"1996","unstructured":"Patel SS, Benfield P, Nevirapine (1996) Clin Immunother 6(4):307\u2013317. https:\/\/doi.org\/10.1007\/BF03259093","journal-title":"Clin Immunother"},{"issue":"3","key":"11568_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1586\/14787210.2.3.367","volume":"2","author":"A Milinkovic","year":"2004","unstructured":"Milinkovic A, Mart\u00ednez E (2004) Nevirapine in the treatment of HIV. Expert Rev Anti Infect Ther 2(3):367\u2013373. https:\/\/doi.org\/10.1586\/14787210.2.3.367","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"11568_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00003088-200140030-00005","volume":"40","author":"JQ Tran","year":"2001","unstructured":"Tran JQ, Gerber JG, Kerr BM Delavirdine: Clinical pharmacokinetics and drug interactions. Clin Pharmacokinet (2001), 40(3), 207\u2013226. https:\/\/doi.org\/10.2165\/00003088-200140030-00005","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"11568_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2165\/00003495-199856060-00014","volume":"56","author":"JC Adkins","year":"1998","unstructured":"Adkins JC, Noble S, Efavirenz (1998) Drugs 56(6):1055\u20131064. https:\/\/doi.org\/10.2165\/00003495-199856060-00014","journal-title":"Drugs"},{"issue":"16","key":"11568_CR18","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2165\/0003495-200868160-00007","volume":"68","author":"ED Deeks","year":"2008","unstructured":"Deeks ED, Keating GM, Etravirine (2008) Drugs 68(16):2357\u20132372. https:\/\/doi.org\/10.2165\/0003495-200868160-00007","journal-title":"Drugs"},{"issue":"4","key":"11568_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/14787210.6.4.427","volume":"6","author":"E Seminari","year":"2008","unstructured":"Seminari E, Castagna A, Lazzarin A (2008) Etravirine for the treatment of HIV Infection. Expert Rev Anti Infect Ther 6(4):427\u2013433. https:\/\/doi.org\/10.1586\/14787210.6.4.427","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"11568_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2165\/11208590-000000000-00000","volume":"72","author":"M Sanford","year":"2012","unstructured":"Sanford M, Rilpivirine (2012) Drugs 72(4):525\u2013541. https:\/\/doi.org\/10.2165\/11208590-000000000-00000","journal-title":"Drugs"},{"issue":"7","key":"11568_CR21","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.3390\/ijms25073659","volume":"25","author":"B Sever","year":"2024","unstructured":"Sever B, Otsuka M, Fujita M, Ciftci HA (2024) Review of FDA-approved Anti-HIV-1 Drugs, anti-gag compounds, and potential strategies for HIV-1 Eradication. Int J Mol Sci 25(7):3659. https:\/\/doi.org\/10.3390\/ijms25073659","journal-title":"Int J Mol Sci"},{"issue":"15","key":"11568_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s40265-018-0993-4","volume":"78","author":"E Deeks","year":"2018","unstructured":"Deeks E (2018) D Doravirine: First global approval. Drugs 78 15 1643\u20131650 https:\/\/doi.org\/10.1007\/s40265-018-0993-4","journal-title":"Drugs"},{"issue":"2","key":"11568_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/03602532.2024.2313967","volume":"56","author":"SM Khalil","year":"2024","unstructured":"Khalil SM, MacKenzie KR, Maletic-Savatic M, Li F (2024) Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity. Drug Metab Rev 56(2):97\u2013126. https:\/\/doi.org\/10.1080\/03602532.2024.2313967","journal-title":"Drug Metab Rev"},{"issue":"6","key":"11568_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1258\/095646206777323346","volume":"17","author":"BO Taiwo","year":"2006","unstructured":"Taiwo BO, Nevirapine Toxicity (2006) Int J STD AIDS 17(6):364\u2013370. https:\/\/doi.org\/10.1258\/095646206777323346","journal-title":"Int J STD AIDS"},{"issue":"5","key":"11568_CR25","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3390\/ijms26052006","volume":"26","author":"BR Maris","year":"2025","unstructured":"Maris BR, Grama A, Pop TL (2025) Drug-induced liver injury\u2014pharmacological spectrum among children. Int J Mol Sci 26(5):2006. https:\/\/doi.org\/10.3390\/ijms26052006","journal-title":"Int J Mol Sci"},{"issue":"9","key":"11568_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2165\/10895940-000000000-00000","volume":"48","author":"M Sch\u00f6ller-Gy\u00fcre","year":"2009","unstructured":"Sch\u00f6ller-Gy\u00fcre M, Kakuda TN, Raoof A, De Smedt G, Hoetelmans RMW (2009) Clinical pharmacokinetics and pharmacodynamics of etravirine. Clin Pharmacokinet 48(9):561\u2013574. https:\/\/doi.org\/10.2165\/10895940-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"11568_CR27","doi-asserted-by":"publisher","unstructured":"Ford N, Lee A-M (2011) Calmy. safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings. HIVAIDS - Res Palliat Care 35. https:\/\/doi.org\/10.2147\/HIV.S14559","DOI":"10.2147\/HIV.S14559"},{"issue":"12","key":"11568_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s40262-019-00806-9","volume":"58","author":"A Boyle","year":"2019","unstructured":"Boyle A, Hodge D, Marzolini C, Khoo S (2019) Clinical pharmacodynamics, pharmacokinetics, and drug interaction profile of doravirine. Clin Pharmacokinet 58(12):1553\u20131565. https:\/\/doi.org\/10.1007\/s40262-019-00806-9","journal-title":"Clin Pharmacokinet"},{"issue":"90001","key":"11568_CR29","doi-asserted-by":"publisher","first-page":"D302","DOI":"10.1093\/nar\/gkj120","volume":"34","author":"A Kouranov","year":"2006","unstructured":"Kouranov A (2006) The RCSB PDB Information portal for structural genomics. Nucleic Acids Res 34(90001):D302\u2013D305. https:\/\/doi.org\/10.1093\/nar\/gkj120","journal-title":"Nucleic Acids Res"},{"key":"11568_CR30","unstructured":"Discovery studio."},{"issue":"1","key":"11568_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2009\u2013\u2009A Free Database of commercially available compounds for virtual screening. J Chem Inf Model 45(1):177\u2013182. https:\/\/doi.org\/10.1021\/ci049714+","journal-title":"J Chem Inf Model"},{"issue":"D1","key":"11568_CR32","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100\u2013D1107. https:\/\/doi.org\/10.1093\/nar\/gkr777","journal-title":"Nucleic Acids Res"},{"key":"11568_CR33","unstructured":"Biosolve IT LeadIT. http:\/\/www.biosolveit.de"},{"issue":"3","key":"11568_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"M Rarey","year":"1996","unstructured":"Rarey M, Kramer B, Lengauer T, Klebe GA (1996) Fast flexible docking method using an incremental construction algorithm. J Mol Biol 261(3):470\u2013489. https:\/\/doi.org\/10.1006\/jmbi.1996.0477","journal-title":"J Mol Biol"},{"issue":"3","key":"11568_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"M Rarey","year":"1996","unstructured":"Rarey M, Kramer B, Lengauer T, Klebe GA (1996) Fast flexible docking method using an incremental construction algorithm. J Mol Biol 261(3):470\u2013489. https:\/\/doi.org\/10.1006\/jmbi.1996.0477","journal-title":"J Mol Biol"},{"key":"11568_CR36","unstructured":"Software a discovery studio visualizer."},{"issue":"8","key":"11568_CR37","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE (2010) Improved side\u2010chain torsion potentials for the amber ff99sb protein force field. Proteins Struct Funct Bioinforma 78(8):1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711","journal-title":"Proteins Struct Funct Bioinforma"},{"issue":"1","key":"11568_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"SD Silva","year":"2012","unstructured":"Silva SD, Vranken AW (2012) ACPYPE - AnteChamber python parser interfacE. BMC Res Notes 5(1):367. https:\/\/doi.org\/10.1186\/1756-0500-5-367","journal-title":"BMC Res Notes"},{"issue":"12","key":"11568_CR39","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh ewald: an N \u22c5log(N) method for ewald sums in large systems. J Chem Phys 98(12):10089\u201310092. https:\/\/doi.org\/10.1063\/1.464397","journal-title":"J Chem Phys"},{"issue":"12","key":"11568_CR40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A Linear constraint solver for molecular simulations. J Comput Chem 18(12):1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12%253C1463::AID-JCC4%253E3.0.CO;2-H","journal-title":"J Comput Chem"},{"issue":"1","key":"11568_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten KVMD (1996) Visual molecular dynamics. J Mol Graph 14(1):33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"issue":"13","key":"11568_CR42","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"issue":"12","key":"11568_CR43","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1021\/jm049081q","volume":"48","author":"B Kuhn","year":"2005","unstructured":"Kuhn B, Gerber P, Schulz-Gasch T, Stahl M (2005) Validation and use of the MM-PBSA approach for drug discovery. J Med Chem 48(12):4040\u20134048. https:\/\/doi.org\/10.1021\/jm049081q","journal-title":"J Med Chem"},{"issue":"10","key":"11568_CR44","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E,gmx-MMPBSA:(2021) A new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput 17(10):6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"issue":"12","key":"11568_CR45","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1021\/jm0200299","volume":"45","author":"P Cozzini","year":"2002","unstructured":"Cozzini P, Fornabaio M, Marabotti A, Abraham DJ, Kellogg GE, Mozzarelli A, Simple (2002) intuitive calculations of free energy of binding for protein\u2013ligand complexes. 1. models without explicit constrained water. J Med Chem 45(12):2469\u20132483. https:\/\/doi.org\/10.1021\/jm0200299","journal-title":"J Med Chem"},{"issue":"28","key":"11568_CR46","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1021\/jp0104029","volume":"105","author":"DM Huang","year":"2001","unstructured":"Huang DM, Geissler PL, Chandler D (2001) Scaling of hydrophobic solvation free energies. J Phys Chem B 105(28):6704\u20136709. https:\/\/doi.org\/10.1021\/jp0104029","journal-title":"J Phys Chem B"},{"issue":"6050","key":"11568_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/319199a0","volume":"319","author":"D Eisenberg","year":"1986","unstructured":"Eisenberg D, McLachlan AD (1986) Solvation energy in protein folding and binding. nature 319(6050):199\u2013203. https:\/\/doi.org\/10.1038\/319199a0","journal-title":"Nature"},{"issue":"2","key":"11568_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0006-3495(96)79641-8","volume":"70","author":"CM Roth","year":"1996","unstructured":"Roth CM, Neal BL, Lenhoff AM (1996) Van der waals interactions involving proteins. Biophys J 70(2):977\u2013987. https:\/\/doi.org\/10.1016\/S0006-3495(96)79641-8","journal-title":"Biophys J"},{"issue":"21","key":"11568_CR49","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1063\/1.471551","volume":"104","author":"DV Matyushov","year":"1996","unstructured":"Matyushov DV, Schmid R (1996) Calculation of Lennard-Jones energies of molecular fluids. J Chem Phys 104(21):8627\u20138638. https:\/\/doi.org\/10.1063\/1.471551","journal-title":"J Chem Phys"},{"key":"11568_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s11581-026-07007-y","author":"E Khodayar","year":"2026","unstructured":"Khodayar E, Zare M (2026) Evaluation of quinine-based ionic liquids as SARS-CoV-2 main protease inhibitors: insights from molecular dynamics simulations. Ionics. https:\/\/doi.org\/10.1007\/s11581-026-07007-y","journal-title":"Ionics"},{"issue":"17","key":"11568_CR51","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1021\/jacs.6b02682","volume":"138","author":"L Duan","year":"2016","unstructured":"Duan L, Liu X, Zhang JZH, Interaction Entropy (2016) A new paradigm for highly efficient and reliable computation of protein\u2013ligand binding free energy. J Am Chem Soc 138(17):5722\u20135728. https:\/\/doi.org\/10.1021\/jacs.6b02682","journal-title":"J Am Chem Soc"},{"issue":"8","key":"11568_CR52","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1021\/acs.jctc.1c00374","volume":"17","author":"V Ekberg","year":"2021","unstructured":"Ekberg V, Ryde U (2021) On the use of interaction entropy and related methods to estimate binding entropies. J Chem Theory Comput 17(8):5379\u20135391. https:\/\/doi.org\/10.1021\/acs.jctc.1c00374","journal-title":"J Chem Theory Comput"},{"key":"11568_CR53","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H (2016) Gaussian 16 software program. Gaussian Inc Wallingford CT"},{"issue":"6","key":"11568_CR54","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","volume":"38","author":"AD Becke","year":"1988","unstructured":"Becke AD (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38(6):3098\u20133100. https:\/\/doi.org\/10.1103\/PhysRevA.38.3098","journal-title":"Phys Rev A"},{"issue":"2","key":"11568_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"C Lee","year":"1988","unstructured":"Lee C, Yang W, Parr RG (1988) Development of the colle-salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37(2):785\u2013789. https:\/\/doi.org\/10.1103\/PhysRevB.37.785","journal-title":"Phys Rev B"},{"key":"11568_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.saa.2015.02.103","volume":"145","author":"CR Legler","year":"2015","unstructured":"Legler CR, Brown NR, Dunbar RA, Harness MD, Nguyen K, Oyewole O, Collier WB (2015) Scaled quantum mechanical scale factors for vibrational calculations using alternate polarized and augmented basis sets with the b3lyp density functional calculation model. Spectrochim Acta Mol Biomol Spectrosc 145:15\u201324. https:\/\/doi.org\/10.1016\/j.saa.2015.02.103","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"issue":"9","key":"11568_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jcc.1058","volume":"22","author":"VA Rassolov","year":"2001","unstructured":"Rassolov VA, Ratner MA, Pople JA, Redfern PC, Curtiss LA (2001) 6-31G* basis set for third\u2010row atoms. J Comput Chem 22(9):976\u2013984. https:\/\/doi.org\/10.1002\/jcc.1058","journal-title":"J Comput Chem"},{"issue":"1","key":"11568_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00894-016-3175-x","volume":"23","author":"Y Huang","year":"2017","unstructured":"Huang Y, Rong C, Zhang R, Liu S (2017) Evaluating frontier orbital energy and HOMO\/LUMO Gap with descriptors from density functional reactivity theory. J Mol Model 23(1):3. https:\/\/doi.org\/10.1007\/s00894-016-3175-x","journal-title":"J Mol Model"},{"issue":"16","key":"11568_CR59","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1021\/j100118a003","volume":"97","author":"RG Parr","year":"1993","unstructured":"Parr RG, Gazquez JL, Hardness functional (1993) J Phys Chem 97(16):3939\u20133940. https:\/\/doi.org\/10.1021\/j100118a003","journal-title":"J Phys Chem"},{"issue":"S22","key":"11568_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/qua.560340840","volume":"34","author":"RF Nalewajski","year":"1988","unstructured":"Nalewajski RF, Korchowiec J, Zhou Z (1988) Molecular hardness and softness parameters and their use in chemistry. Int J Quantum Chem 34(S22):349\u2013366. https:\/\/doi.org\/10.1002\/qua.560340840","journal-title":"Int J Quantum Chem"},{"issue":"17","key":"11568_CR61","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1021\/ja01478a001","volume":"83","author":"RP Iczkowski","year":"1961","unstructured":"Iczkowski RP, Margrave JL, Electronegativity. (1961) J Am Chem Soc 83(17):3547\u20133551. https:\/\/doi.org\/10.1021\/ja01478a001","journal-title":"J Am Chem Soc"},{"issue":"25","key":"11568_CR62","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1021\/jp034707u","volume":"107","author":"PK Chattaraj","year":"2003","unstructured":"Chattaraj PK, Maiti B, Sarkar U, Philicity (2003) A unified treatment of chemical reactivity and selectivity. J Phys Chem A 107(25):4973\u20134975. https:\/\/doi.org\/10.1021\/jp034707u","journal-title":"J Phys Chem A"},{"issue":"15","key":"11568_CR63","doi-asserted-by":"publisher","first-page":"154103","DOI":"10.1063\/1.4932539","volume":"143","author":"M Franco-P\u00e9rez","year":"2015","unstructured":"Franco-P\u00e9rez M, G\u00e1zquez JL, Ayers PW, Vela A (2015) Revisiting the definition of the electronic chemical potential, chemical hardness, and softness at finite temperatures. J Chem Phys 143(15):154103. https:\/\/doi.org\/10.1063\/1.4932539","journal-title":"J Chem Phys"},{"key":"11568_CR64","unstructured":"Dennington R, Keith TA, Millam JM (2016) GaussView 6.0. 16. Semichem Inc Shawnee Mission KS USA 143\u2013150"},{"issue":"1\u20136","key":"11568_CR65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0031-8914(34)90011-2","volume":"1","author":"T Koopmans","year":"1934","unstructured":"Koopmans T (1934) \u00dcber die zuordnung von wellenfunktionen und eigenwerten zu den einzelnen elektronen eines atoms. physica 1(1\u20136):104\u2013113","journal-title":"physica"},{"key":"11568_CR66","doi-asserted-by":"publisher","unstructured":"Klein DJ, Zebisch M, Gu MHIV (2022) Reverse transcriptase with compound Pyr02: 7sls. https:\/\/doi.org\/10.2210\/pdb7sls\/pdb","DOI":"10.2210\/pdb7sls\/pdb"},{"key":"11568_CR67","doi-asserted-by":"publisher","first-page":"118403","DOI":"10.1016\/j.ejmech.2025.118403","volume":"303","author":"X Ye","year":"2026","unstructured":"Ye X, Deng S, Luo D, Fu W, Du Q, Xue W (2026) Discovery of a new allosteric inhibitor for human dopamine transporter by physics-based modeling and experimental validation. Eur J Med Chem 303:118403. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118403","journal-title":"Eur J Med Chem"},{"issue":"8","key":"11568_CR68","doi-asserted-by":"publisher","first-page":"101368","DOI":"10.1016\/j.jpha.2025.101368","volume":"15","author":"D Luo","year":"2025","unstructured":"Luo D, Sha Z, Mao J, Liu J, Zhou Y, Wu H, Xue W (2025) Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation. J Pharm Anal 15(8):101368. https:\/\/doi.org\/10.1016\/j.jpha.2025.101368","journal-title":"J Pharm Anal"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11568-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11568-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:44Z","timestamp":1791121664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11568-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11568"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11568-5","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}